Hence, AST possesses the ability to oppose diabetic CVD-associated AD due to its potential blood glucose regulation, reductions in tissue extravasation, reversal of the neuronal nitrite, prevention of β-amyloid protein accumulation, and inhibition of MMP-13 and AChE activities. Here, MMP13 is linked to Alzheimer disease.